PATENT CLAIM ANALYSIS

Application Number: 16100424
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "315000"]

Abstract:
The methods disclosed herein relate to the treatment of chronic inflammatory dermal disorder in humans, by administering a therapeutically effective amount of RS-norketotifen.

Claim (Index 3):
The method of  claim 1 , wherein said dermal disorder selected from the group consisting of eczema, atopic dermatitis, urticaria and psoriasis.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 96.0
- Lexical Diversity: 1.04167
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15071546', '13739090', '14025302', '12378231', '11796998']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.811013362117981
- 35 USC 102 Novelty (BERT): 0.5064484888437196
- Combined Prediction Score: 0.7805568747905549
- Mean Citation Score: 265.179812
- Max Citation Score: 287.68826
- Similarity Product: 222.27914563118225

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test